**Core Concept**
Central anticholinergic syndrome, also known as anticholinergic toxicity, is a condition characterized by the systemic effects of anticholinergic agents. These agents block the action of acetylcholine at muscarinic and nicotinic receptors in the central nervous system, leading to a range of symptoms including delirium, confusion, and altered mental status.

**Why the Correct Answer is Right**
The correct answer does not produce central anticholinergic syndrome because it does not cross the blood-brain barrier (BBB) in significant amounts. The BBB restricts the passage of certain substances, including most anticholinergic drugs, to the central nervous system. As a result, the drug does not cause significant anticholinergic effects in the brain.

**Why Each Wrong Option is Incorrect**
* **Option A:** This drug is a well-known anticholinergic agent that can cause central anticholinergic syndrome by blocking muscarinic receptors in the brain. It can lead to delirium, confusion, and other systemic effects.
* **Option B:** This drug also has anticholinergic properties and can cause central anticholinergic syndrome by affecting muscarinic receptors in the central nervous system.
* **Option D:** This drug is another anticholinergic agent that can cause central anticholinergic syndrome by blocking muscarinic receptors in the brain.

**Clinical Pearl / High-Yield Fact**
The blood-brain barrier is a critical structure that restricts the passage of certain substances to the central nervous system. Understanding the BBB's role in limiting the effects of certain drugs is essential for medical professionals to avoid adverse reactions and optimize treatment outcomes.

**Correct Answer:** C.